Frank Rimerman Advisors LLC Reduces Holdings in The Allstate Corporation $ALL

Frank Rimerman Advisors LLC lowered its position in The Allstate Corporation (NYSE:ALL) by 8.1% in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 2,993 shares of the insurance provider’s stock after selling 264 shares during the quarter. Frank Rimerman Advisors LLC’s holdings in Allstate were worth $603,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in ALL. Brighton Jones LLC raised its position in shares of Allstate by 60.2% in the fourth quarter. Brighton Jones LLC now owns 6,500 shares of the insurance provider’s stock valued at $1,253,000 after purchasing an additional 2,443 shares during the period. Revolve Wealth Partners LLC purchased a new position in Allstate in the 4th quarter valued at approximately $231,000. Private Advisor Group LLC grew its stake in Allstate by 0.9% in the 1st quarter. Private Advisor Group LLC now owns 18,007 shares of the insurance provider’s stock valued at $3,729,000 after buying an additional 167 shares in the last quarter. IFP Advisors Inc raised its holdings in Allstate by 15.4% during the 1st quarter. IFP Advisors Inc now owns 1,032 shares of the insurance provider’s stock valued at $214,000 after acquiring an additional 138 shares during the period. Finally, Crestwood Advisors Group LLC lifted its position in shares of Allstate by 23.1% during the first quarter. Crestwood Advisors Group LLC now owns 1,514 shares of the insurance provider’s stock worth $314,000 after acquiring an additional 284 shares in the last quarter. 76.47% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Allstate

In other news, insider Suren Gupta sold 400 shares of Allstate stock in a transaction on Monday, November 17th. The shares were sold at an average price of $215.22, for a total transaction of $86,088.00. Following the completion of the sale, the insider directly owned 100,646 shares of the company’s stock, valued at approximately $21,661,032.12. The trade was a 0.40% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 1.70% of the company’s stock.

Allstate Stock Performance

Shares of ALL opened at $209.89 on Thursday. The Allstate Corporation has a 12-month low of $176.00 and a 12-month high of $215.70. The company has a current ratio of 0.43, a quick ratio of 0.43 and a debt-to-equity ratio of 0.37. The company has a market cap of $54.92 billion, a PE ratio of 9.87, a price-to-earnings-growth ratio of 0.69 and a beta of 0.35. The stock has a 50-day moving average price of $202.92 and a 200-day moving average price of $201.91.

Allstate (NYSE:ALL) last announced its earnings results on Wednesday, November 5th. The insurance provider reported $11.17 earnings per share for the quarter, beating analysts’ consensus estimates of $5.48 by $5.69. Allstate had a net margin of 8.79% and a return on equity of 28.74%. The business had revenue of $17.26 billion for the quarter, compared to the consensus estimate of $16.59 billion. During the same period last year, the firm posted $3.91 earnings per share. Allstate’s quarterly revenue was up 3.8% on a year-over-year basis. As a group, equities analysts forecast that The Allstate Corporation will post 18.74 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the company. JPMorgan Chase & Co. lifted their price target on Allstate from $254.00 to $260.00 and gave the company an “overweight” rating in a research report on Thursday, November 6th. Wall Street Zen downgraded Allstate from a “strong-buy” rating to a “buy” rating in a research note on Saturday, November 8th. Roth Capital set a $230.00 target price on Allstate and gave the company a “buy” rating in a report on Friday, September 26th. BMO Capital Markets increased their price target on shares of Allstate from $235.00 to $244.00 and gave the stock an “outperform” rating in a report on Friday, November 7th. Finally, Evercore ISI set a $233.00 price objective on shares of Allstate and gave the company an “in-line” rating in a research report on Wednesday, October 1st. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $237.64.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.